Sean Swayze, the younger brother of actor Patrick Swayze, died at age 63 in Los Angeles due to complications from liver cirrhosis and other health issues, leaving behind a son and daughter, and remembered fondly by family and friends.
A study suggests that up to 10% of dementia patients may actually have liver cirrhosis, leading to symptoms similar to dementia. This condition, known as hepatic encephalitis, can sometimes be reversed through medication, lifestyle changes, or liver transplant. Researchers found that many dementia patients may have been misdiagnosed and could potentially see improvements in mental function by treating the underlying liver problem. The study highlights the importance of screening for liver cirrhosis in dementia patients and suggests that as many as 670,000 Americans may have been wrongly diagnosed with dementia.
A new observational study suggests that the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in adults with type 2 diabetes and compensated liver cirrhosis can lower the risk of death, cardiovascular disease, decompensated cirrhosis, and liver failure. The study found that GLP-1 RA users had significantly lower risks for mortality, cardiovascular events, decompensated cirrhosis, hepatic encephalopathy, and liver failure compared to nonusers. The researchers suggest that GLP-1 RAs may be a treatment option for diabetes patients with liver cirrhosis, but further studies are needed to confirm these results and explore the mechanisms involved.